nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—CYP2C19—Methazolamide—glaucoma	0.0737	0.32	CbGbCtD
Telmisartan—CYP2C19—Timolol—glaucoma	0.0627	0.273	CbGbCtD
Telmisartan—ABCB1—Timolol—glaucoma	0.0506	0.22	CbGbCtD
Telmisartan—ABCB1—Clonidine—glaucoma	0.043	0.187	CbGbCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00111	0.0108	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00106	0.0103	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00102	0.00987	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—TGFB2—glaucoma	0.000983	0.00952	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000966	0.00936	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors—NR3C1—glaucoma	0.000962	0.00931	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—OPN4—glaucoma	0.000927	0.00897	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000918	0.00889	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000873	0.00846	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.00087	0.00842	CbGpPWpGaD
Telmisartan—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000844	0.00817	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000786	0.00761	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CCND2—glaucoma	0.000786	0.00761	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL1A—glaucoma	0.000782	0.00757	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00076	0.00736	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00075	0.00726	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.000737	0.00714	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.000732	0.00709	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000727	0.00704	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—FAS—glaucoma	0.000697	0.00675	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.000691	0.00669	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—C3—glaucoma	0.000687	0.00665	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—OPN4—glaucoma	0.000665	0.00644	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000652	0.00631	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000645	0.00624	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000616	0.00596	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000612	0.00593	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TXN—glaucoma	0.000601	0.00582	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—PTGFR—glaucoma	0.000599	0.0058	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00056	0.00542	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—ABCA1—glaucoma	0.000555	0.00538	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000544	0.00526	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000536	0.00519	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000536	0.00519	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000527	0.0051	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00052	0.00504	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000493	0.00477	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000491	0.00476	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000472	0.00457	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—glaucoma	0.00047	0.00456	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000452	0.00438	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000437	0.00423	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000429	0.00415	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.000427	0.00413	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000425	0.00412	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000422	0.00408	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN2A—glaucoma	0.000403	0.0039	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CA5A—glaucoma	0.0004	0.00388	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NARFL—glaucoma	0.0004	0.00388	CbGpPWpGaD
Telmisartan—Arrhythmia—Betaxolol—glaucoma	0.000399	0.000599	CcSEcCtD
Telmisartan—Feeling abnormal—Dorzolamide—glaucoma	0.000398	0.000598	CcSEcCtD
Telmisartan—Decreased appetite—Pilocarpine—glaucoma	0.000397	0.000596	CcSEcCtD
Telmisartan—Feeling abnormal—Travoprost—glaucoma	0.000397	0.000595	CcSEcCtD
Telmisartan—Conjunctivitis—Timolol—glaucoma	0.000395	0.000593	CcSEcCtD
Telmisartan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000395	0.000593	CcSEcCtD
Telmisartan—Palpitations—Clonidine—glaucoma	0.000395	0.000592	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—EDN1—glaucoma	0.000395	0.00382	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000394	0.000592	CcSEcCtD
Telmisartan—Gastrointestinal pain—Travoprost—glaucoma	0.000394	0.00059	CcSEcCtD
Telmisartan—Loss of consciousness—Clonidine—glaucoma	0.000393	0.000589	CcSEcCtD
Telmisartan—Feeling abnormal—Brinzolamide—glaucoma	0.000392	0.000587	CcSEcCtD
Telmisartan—Mental disorder—Betaxolol—glaucoma	0.000392	0.000587	CcSEcCtD
Telmisartan—Pain—Pilocarpine—glaucoma	0.000391	0.000586	CcSEcCtD
Telmisartan—Constipation—Pilocarpine—glaucoma	0.000391	0.000586	CcSEcCtD
Telmisartan—Cough—Clonidine—glaucoma	0.00039	0.000585	CcSEcCtD
Telmisartan—Dizziness—Apraclonidine—glaucoma	0.00039	0.000585	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.00039	0.00377	CbGpPWpGaD
Telmisartan—Erythema—Betaxolol—glaucoma	0.000389	0.000584	CcSEcCtD
Telmisartan—Malnutrition—Betaxolol—glaucoma	0.000389	0.000584	CcSEcCtD
Telmisartan—Urticaria—Dorzolamide—glaucoma	0.000384	0.000576	CcSEcCtD
Telmisartan—Epistaxis—Timolol—glaucoma	0.000384	0.000575	CcSEcCtD
Telmisartan—Body temperature increased—Dorzolamide—glaucoma	0.000382	0.000573	CcSEcCtD
Telmisartan—Abdominal pain—Dorzolamide—glaucoma	0.000382	0.000573	CcSEcCtD
Telmisartan—Tension—Betaxolol—glaucoma	0.000382	0.000573	CcSEcCtD
Telmisartan—Sinusitis—Timolol—glaucoma	0.000382	0.000572	CcSEcCtD
Telmisartan—Dysgeusia—Betaxolol—glaucoma	0.000381	0.000572	CcSEcCtD
Telmisartan—Arthralgia—Clonidine—glaucoma	0.000381	0.000571	CcSEcCtD
Telmisartan—Chest pain—Clonidine—glaucoma	0.000381	0.000571	CcSEcCtD
Telmisartan—Abdominal pain—Travoprost—glaucoma	0.000381	0.000571	CcSEcCtD
Telmisartan—Anxiety—Clonidine—glaucoma	0.000379	0.000569	CcSEcCtD
Telmisartan—Asthenia—Acetazolamide—glaucoma	0.000378	0.000568	CcSEcCtD
Telmisartan—Dizziness—Bimatoprost—glaucoma	0.000378	0.000567	CcSEcCtD
Telmisartan—Nervousness—Betaxolol—glaucoma	0.000378	0.000567	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000378	0.000567	CcSEcCtD
Telmisartan—Urticaria—Brinzolamide—glaucoma	0.000378	0.000566	CcSEcCtD
Telmisartan—Feeling abnormal—Pilocarpine—glaucoma	0.000376	0.000565	CcSEcCtD
Telmisartan—Discomfort—Clonidine—glaucoma	0.000376	0.000564	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—OPN4—glaucoma	0.000376	0.00364	CbGpPWpGaD
Telmisartan—Vomiting—Apraclonidine—glaucoma	0.000375	0.000562	CcSEcCtD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000375	0.00363	CbGpPWpGaD
Telmisartan—Muscle spasms—Betaxolol—glaucoma	0.000374	0.000561	CcSEcCtD
Telmisartan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000374	0.00056	CcSEcCtD
Telmisartan—Hypersensitivity—Brimonidine—glaucoma	0.000373	0.000559	CcSEcCtD
Telmisartan—Dry mouth—Clonidine—glaucoma	0.000372	0.000558	CcSEcCtD
Telmisartan—Bradycardia—Timolol—glaucoma	0.000372	0.000558	CcSEcCtD
Telmisartan—Dermatitis—Apraclonidine—glaucoma	0.000371	0.000557	CcSEcCtD
Telmisartan—Headache—Apraclonidine—glaucoma	0.000369	0.000554	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000368	0.00356	CbGpPWpGaD
Telmisartan—Rhinitis—Timolol—glaucoma	0.000366	0.000549	CcSEcCtD
Telmisartan—Oedema—Clonidine—glaucoma	0.000365	0.000547	CcSEcCtD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000364	0.00353	CbGpPWpGaD
Telmisartan—Asthenia—Brimonidine—glaucoma	0.000363	0.000545	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000363	0.00351	CbGpPWpGaD
Telmisartan—Infection—Clonidine—glaucoma	0.000362	0.000544	CcSEcCtD
Telmisartan—Body temperature increased—Pilocarpine—glaucoma	0.000361	0.000542	CcSEcCtD
Telmisartan—Abdominal pain—Pilocarpine—glaucoma	0.000361	0.000542	CcSEcCtD
Telmisartan—Ill-defined disorder—Betaxolol—glaucoma	0.000361	0.000542	CcSEcCtD
Telmisartan—Diarrhoea—Acetazolamide—glaucoma	0.000361	0.000541	CcSEcCtD
Telmisartan—Rash—Bimatoprost—glaucoma	0.00036	0.000541	CcSEcCtD
Telmisartan—Dermatitis—Bimatoprost—glaucoma	0.00036	0.00054	CcSEcCtD
Telmisartan—Oedema peripheral—Timolol—glaucoma	0.00036	0.00054	CcSEcCtD
Telmisartan—Anaemia—Betaxolol—glaucoma	0.00036	0.000539	CcSEcCtD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00036	0.00348	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—NR3C1—glaucoma	0.000359	0.00348	CbGpPWpGaD
Telmisartan—Shock—Clonidine—glaucoma	0.000359	0.000538	CcSEcCtD
Telmisartan—Connective tissue disorder—Timolol—glaucoma	0.000359	0.000538	CcSEcCtD
Telmisartan—Pruritus—Brimonidine—glaucoma	0.000358	0.000537	CcSEcCtD
Telmisartan—Headache—Bimatoprost—glaucoma	0.000358	0.000537	CcSEcCtD
Telmisartan—Nervous system disorder—Clonidine—glaucoma	0.000358	0.000537	CcSEcCtD
Telmisartan—Thrombocytopenia—Clonidine—glaucoma	0.000357	0.000536	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN1B—glaucoma	0.000357	0.00346	CbGpPWpGaD
Telmisartan—Hypersensitivity—Dorzolamide—glaucoma	0.000356	0.000534	CcSEcCtD
Telmisartan—Tachycardia—Clonidine—glaucoma	0.000356	0.000534	CcSEcCtD
Telmisartan—Hypersensitivity—Travoprost—glaucoma	0.000355	0.000532	CcSEcCtD
Telmisartan—Skin disorder—Clonidine—glaucoma	0.000354	0.000531	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000353	0.00342	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Clonidine—glaucoma	0.000353	0.000529	CcSEcCtD
Telmisartan—Visual impairment—Timolol—glaucoma	0.000352	0.000528	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000351	0.0034	CbGpPWpGaD
Telmisartan—Malaise—Betaxolol—glaucoma	0.000351	0.000526	CcSEcCtD
Telmisartan—Nausea—Apraclonidine—glaucoma	0.00035	0.000525	CcSEcCtD
Telmisartan—Hypersensitivity—Brinzolamide—glaucoma	0.00035	0.000525	CcSEcCtD
Telmisartan—Vertigo—Betaxolol—glaucoma	0.00035	0.000524	CcSEcCtD
Telmisartan—Syncope—Betaxolol—glaucoma	0.000349	0.000523	CcSEcCtD
Telmisartan—Dizziness—Acetazolamide—glaucoma	0.000349	0.000523	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—FAS—glaucoma	0.000348	0.00337	CbGpPWpGaD
Telmisartan—Anorexia—Clonidine—glaucoma	0.000348	0.000522	CcSEcCtD
Telmisartan—Asthenia—Dorzolamide—glaucoma	0.000347	0.00052	CcSEcCtD
Telmisartan—Asthenia—Travoprost—glaucoma	0.000345	0.000518	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—glaucoma	0.000345	0.00334	CbGpPWpGaD
Telmisartan—Palpitations—Betaxolol—glaucoma	0.000344	0.000516	CcSEcCtD
Telmisartan—Pruritus—Dorzolamide—glaucoma	0.000342	0.000513	CcSEcCtD
Telmisartan—Loss of consciousness—Betaxolol—glaucoma	0.000342	0.000513	CcSEcCtD
Telmisartan—PPARG—Metabolism—CA5A—glaucoma	0.000342	0.00331	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NARFL—glaucoma	0.000342	0.00331	CbGpPWpGaD
Telmisartan—Eye disorder—Timolol—glaucoma	0.000341	0.000512	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—OPN4—glaucoma	0.000341	0.0033	CbGpPWpGaD
Telmisartan—Asthenia—Brinzolamide—glaucoma	0.000341	0.000511	CcSEcCtD
Telmisartan—Hypotension—Clonidine—glaucoma	0.000341	0.000511	CcSEcCtD
Telmisartan—Pruritus—Travoprost—glaucoma	0.000341	0.000511	CcSEcCtD
Telmisartan—Tinnitus—Timolol—glaucoma	0.00034	0.000511	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—C3—glaucoma	0.00034	0.0033	CbGpPWpGaD
Telmisartan—Cough—Betaxolol—glaucoma	0.00034	0.000509	CcSEcCtD
Telmisartan—Nausea—Bimatoprost—glaucoma	0.00034	0.000509	CcSEcCtD
Telmisartan—Cardiac disorder—Timolol—glaucoma	0.000339	0.000508	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—PTGFR—glaucoma	0.000338	0.00328	CbGpPWpGaD
Telmisartan—Hypersensitivity—Pilocarpine—glaucoma	0.000337	0.000505	CcSEcCtD
Telmisartan—Pruritus—Brinzolamide—glaucoma	0.000336	0.000504	CcSEcCtD
Telmisartan—Vomiting—Acetazolamide—glaucoma	0.000335	0.000503	CcSEcCtD
Telmisartan—Dizziness—Brimonidine—glaucoma	0.000335	0.000502	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000332	0.000498	CcSEcCtD
Telmisartan—Angiopathy—Timolol—glaucoma	0.000331	0.000497	CcSEcCtD
Telmisartan—Chest pain—Betaxolol—glaucoma	0.000331	0.000497	CcSEcCtD
Telmisartan—Arthralgia—Betaxolol—glaucoma	0.000331	0.000497	CcSEcCtD
Telmisartan—Myalgia—Betaxolol—glaucoma	0.000331	0.000497	CcSEcCtD
Telmisartan—Diarrhoea—Dorzolamide—glaucoma	0.000331	0.000496	CcSEcCtD
Telmisartan—Headache—Acetazolamide—glaucoma	0.00033	0.000496	CcSEcCtD
Telmisartan—Anxiety—Betaxolol—glaucoma	0.00033	0.000495	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.00033	0.0032	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—NGFR—glaucoma	0.00033	0.0032	CbGpPWpGaD
Telmisartan—Insomnia—Clonidine—glaucoma	0.00033	0.000495	CcSEcCtD
Telmisartan—Immune system disorder—Timolol—glaucoma	0.00033	0.000495	CcSEcCtD
Telmisartan—Diarrhoea—Travoprost—glaucoma	0.000329	0.000494	CcSEcCtD
Telmisartan—Mediastinal disorder—Timolol—glaucoma	0.000329	0.000494	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000329	0.000493	CcSEcCtD
Telmisartan—Asthenia—Pilocarpine—glaucoma	0.000328	0.000492	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000328	0.00317	CbGpPWpGaD
Telmisartan—Paraesthesia—Clonidine—glaucoma	0.000328	0.000491	CcSEcCtD
Telmisartan—Discomfort—Betaxolol—glaucoma	0.000327	0.000491	CcSEcCtD
Telmisartan—Arrhythmia—Timolol—glaucoma	0.000326	0.000489	CcSEcCtD
Telmisartan—Dyspnoea—Clonidine—glaucoma	0.000325	0.000488	CcSEcCtD
Telmisartan—Diarrhoea—Brinzolamide—glaucoma	0.000325	0.000488	CcSEcCtD
Telmisartan—Somnolence—Clonidine—glaucoma	0.000324	0.000486	CcSEcCtD
Telmisartan—Dry mouth—Betaxolol—glaucoma	0.000324	0.000486	CcSEcCtD
Telmisartan—Pruritus—Pilocarpine—glaucoma	0.000323	0.000485	CcSEcCtD
Telmisartan—Mental disorder—Timolol—glaucoma	0.00032	0.00048	CcSEcCtD
Telmisartan—Dizziness—Dorzolamide—glaucoma	0.00032	0.000479	CcSEcCtD
Telmisartan—Rash—Brimonidine—glaucoma	0.000319	0.000479	CcSEcCtD
Telmisartan—Dermatitis—Brimonidine—glaucoma	0.000319	0.000478	CcSEcCtD
Telmisartan—Dizziness—Travoprost—glaucoma	0.000318	0.000477	CcSEcCtD
Telmisartan—Erythema—Timolol—glaucoma	0.000318	0.000477	CcSEcCtD
Telmisartan—Malnutrition—Timolol—glaucoma	0.000318	0.000477	CcSEcCtD
Telmisartan—Oedema—Betaxolol—glaucoma	0.000318	0.000476	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000318	0.00308	CbGpPWpGaD
Telmisartan—Headache—Brimonidine—glaucoma	0.000317	0.000476	CcSEcCtD
Telmisartan—Decreased appetite—Clonidine—glaucoma	0.000317	0.000476	CcSEcCtD
Telmisartan—Infection—Betaxolol—glaucoma	0.000316	0.000473	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Clonidine—glaucoma	0.000315	0.000472	CcSEcCtD
Telmisartan—Fatigue—Clonidine—glaucoma	0.000315	0.000472	CcSEcCtD
Telmisartan—Dizziness—Brinzolamide—glaucoma	0.000314	0.000471	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—NTRK1—glaucoma	0.000314	0.00304	CbGpPWpGaD
Telmisartan—Nausea—Acetazolamide—glaucoma	0.000313	0.00047	CcSEcCtD
Telmisartan—Diarrhoea—Pilocarpine—glaucoma	0.000313	0.000469	CcSEcCtD
Telmisartan—Shock—Betaxolol—glaucoma	0.000312	0.000469	CcSEcCtD
Telmisartan—Tension—Timolol—glaucoma	0.000312	0.000468	CcSEcCtD
Telmisartan—Pain—Clonidine—glaucoma	0.000312	0.000468	CcSEcCtD
Telmisartan—Constipation—Clonidine—glaucoma	0.000312	0.000468	CcSEcCtD
Telmisartan—Nervous system disorder—Betaxolol—glaucoma	0.000311	0.000467	CcSEcCtD
Telmisartan—Dysgeusia—Timolol—glaucoma	0.000311	0.000467	CcSEcCtD
Telmisartan—Thrombocytopenia—Betaxolol—glaucoma	0.000311	0.000466	CcSEcCtD
Telmisartan—Tachycardia—Betaxolol—glaucoma	0.00031	0.000465	CcSEcCtD
Telmisartan—Nervousness—Timolol—glaucoma	0.000309	0.000463	CcSEcCtD
Telmisartan—Skin disorder—Betaxolol—glaucoma	0.000308	0.000463	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—NCK2—glaucoma	0.000308	0.00298	CbGpPWpGaD
Telmisartan—Vomiting—Dorzolamide—glaucoma	0.000307	0.000461	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—PTGFR—glaucoma	0.000307	0.00298	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Betaxolol—glaucoma	0.000307	0.00046	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000306	0.00296	CbGpPWpGaD
Telmisartan—Rash—Dorzolamide—glaucoma	0.000305	0.000457	CcSEcCtD
Telmisartan—Dermatitis—Dorzolamide—glaucoma	0.000305	0.000457	CcSEcCtD
Telmisartan—Rash—Travoprost—glaucoma	0.000303	0.000455	CcSEcCtD
Telmisartan—Dermatitis—Travoprost—glaucoma	0.000303	0.000455	CcSEcCtD
Telmisartan—Headache—Dorzolamide—glaucoma	0.000303	0.000454	CcSEcCtD
Telmisartan—Anorexia—Betaxolol—glaucoma	0.000303	0.000454	CcSEcCtD
Telmisartan—Vomiting—Brinzolamide—glaucoma	0.000302	0.000453	CcSEcCtD
Telmisartan—Dizziness—Pilocarpine—glaucoma	0.000302	0.000453	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—SMO—glaucoma	0.000302	0.00292	CbGpPWpGaD
Telmisartan—Headache—Travoprost—glaucoma	0.000302	0.000452	CcSEcCtD
Telmisartan—Nausea—Brimonidine—glaucoma	0.000301	0.000451	CcSEcCtD
Telmisartan—Feeling abnormal—Clonidine—glaucoma	0.000301	0.000451	CcSEcCtD
Telmisartan—Rash—Brinzolamide—glaucoma	0.0003	0.000449	CcSEcCtD
Telmisartan—Dermatitis—Brinzolamide—glaucoma	0.000299	0.000449	CcSEcCtD
Telmisartan—Gastrointestinal pain—Clonidine—glaucoma	0.000298	0.000447	CcSEcCtD
Telmisartan—Headache—Brinzolamide—glaucoma	0.000298	0.000447	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000297	0.00287	CbGpPWpGaD
Telmisartan—Hypotension—Betaxolol—glaucoma	0.000297	0.000445	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—TNF—glaucoma	0.000296	0.00286	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000295	0.00286	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LRP12—glaucoma	0.000291	0.00282	CbGpPWpGaD
Telmisartan—Angioedema—Timolol—glaucoma	0.00029	0.000436	CcSEcCtD
Telmisartan—Vomiting—Pilocarpine—glaucoma	0.00029	0.000436	CcSEcCtD
Telmisartan—Urticaria—Clonidine—glaucoma	0.00029	0.000435	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000289	0.000434	CcSEcCtD
Telmisartan—Body temperature increased—Clonidine—glaucoma	0.000288	0.000433	CcSEcCtD
Telmisartan—Abdominal pain—Clonidine—glaucoma	0.000288	0.000433	CcSEcCtD
Telmisartan—Rash—Pilocarpine—glaucoma	0.000288	0.000432	CcSEcCtD
Telmisartan—Dermatitis—Pilocarpine—glaucoma	0.000288	0.000432	CcSEcCtD
Telmisartan—Insomnia—Betaxolol—glaucoma	0.000287	0.000431	CcSEcCtD
Telmisartan—Nausea—Dorzolamide—glaucoma	0.000287	0.000431	CcSEcCtD
Telmisartan—Headache—Pilocarpine—glaucoma	0.000286	0.000429	CcSEcCtD
Telmisartan—Nausea—Travoprost—glaucoma	0.000286	0.000429	CcSEcCtD
Telmisartan—Vertigo—Timolol—glaucoma	0.000286	0.000428	CcSEcCtD
Telmisartan—Paraesthesia—Betaxolol—glaucoma	0.000285	0.000428	CcSEcCtD
Telmisartan—Syncope—Timolol—glaucoma	0.000285	0.000428	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000285	0.00276	CbGpPWpGaD
Telmisartan—Dyspnoea—Betaxolol—glaucoma	0.000283	0.000425	CcSEcCtD
Telmisartan—Nausea—Brinzolamide—glaucoma	0.000282	0.000423	CcSEcCtD
Telmisartan—Palpitations—Timolol—glaucoma	0.000281	0.000421	CcSEcCtD
Telmisartan—Dyspepsia—Betaxolol—glaucoma	0.00028	0.000419	CcSEcCtD
Telmisartan—Loss of consciousness—Timolol—glaucoma	0.000279	0.000419	CcSEcCtD
Telmisartan—Cough—Timolol—glaucoma	0.000277	0.000416	CcSEcCtD
Telmisartan—Decreased appetite—Betaxolol—glaucoma	0.000276	0.000414	CcSEcCtD
Telmisartan—Hypertension—Timolol—glaucoma	0.000274	0.000412	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000274	0.000411	CcSEcCtD
Telmisartan—Fatigue—Betaxolol—glaucoma	0.000274	0.000411	CcSEcCtD
Telmisartan—Constipation—Betaxolol—glaucoma	0.000272	0.000407	CcSEcCtD
Telmisartan—Pain—Betaxolol—glaucoma	0.000272	0.000407	CcSEcCtD
Telmisartan—Nausea—Pilocarpine—glaucoma	0.000271	0.000407	CcSEcCtD
Telmisartan—Arthralgia—Timolol—glaucoma	0.000271	0.000406	CcSEcCtD
Telmisartan—Myalgia—Timolol—glaucoma	0.000271	0.000406	CcSEcCtD
Telmisartan—Chest pain—Timolol—glaucoma	0.000271	0.000406	CcSEcCtD
Telmisartan—Anxiety—Timolol—glaucoma	0.00027	0.000405	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000269	0.000403	CcSEcCtD
Telmisartan—Hypersensitivity—Clonidine—glaucoma	0.000269	0.000403	CcSEcCtD
Telmisartan—Discomfort—Timolol—glaucoma	0.000267	0.000401	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000266	0.00258	CbGpPWpGaD
Telmisartan—Dry mouth—Timolol—glaucoma	0.000265	0.000397	CcSEcCtD
Telmisartan—Asthenia—Clonidine—glaucoma	0.000262	0.000393	CcSEcCtD
Telmisartan—Feeling abnormal—Betaxolol—glaucoma	0.000262	0.000393	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000261	0.00253	CbGpPWpGaD
Telmisartan—Oedema—Timolol—glaucoma	0.000259	0.000389	CcSEcCtD
Telmisartan—Anaphylactic shock—Timolol—glaucoma	0.000259	0.000389	CcSEcCtD
Telmisartan—Pruritus—Clonidine—glaucoma	0.000258	0.000387	CcSEcCtD
Telmisartan—Infection—Timolol—glaucoma	0.000258	0.000387	CcSEcCtD
Telmisartan—Shock—Timolol—glaucoma	0.000255	0.000383	CcSEcCtD
Telmisartan—Nervous system disorder—Timolol—glaucoma	0.000254	0.000382	CcSEcCtD
Telmisartan—Urticaria—Betaxolol—glaucoma	0.000252	0.000378	CcSEcCtD
Telmisartan—Skin disorder—Timolol—glaucoma	0.000252	0.000378	CcSEcCtD
Telmisartan—Body temperature increased—Betaxolol—glaucoma	0.000251	0.000377	CcSEcCtD
Telmisartan—Hyperhidrosis—Timolol—glaucoma	0.000251	0.000376	CcSEcCtD
Telmisartan—Diarrhoea—Clonidine—glaucoma	0.00025	0.000374	CcSEcCtD
Telmisartan—ABCG2—Metabolism—NARFL—glaucoma	0.000249	0.00241	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA5A—glaucoma	0.000249	0.00241	CbGpPWpGaD
Telmisartan—Anorexia—Timolol—glaucoma	0.000247	0.000371	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—FAS—glaucoma	0.000246	0.00238	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000245	0.00237	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—glaucoma	0.000243	0.00235	CbGpPWpGaD
Telmisartan—Hypotension—Timolol—glaucoma	0.000242	0.000364	CcSEcCtD
Telmisartan—Dizziness—Clonidine—glaucoma	0.000241	0.000362	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00024	0.00232	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Timolol—glaucoma	0.000236	0.000355	CcSEcCtD
Telmisartan—Insomnia—Timolol—glaucoma	0.000235	0.000352	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000234	0.00227	CbGpPWpGaD
Telmisartan—Hypersensitivity—Betaxolol—glaucoma	0.000234	0.000351	CcSEcCtD
Telmisartan—Paraesthesia—Timolol—glaucoma	0.000233	0.000349	CcSEcCtD
Telmisartan—Vomiting—Clonidine—glaucoma	0.000232	0.000348	CcSEcCtD
Telmisartan—Dyspnoea—Timolol—glaucoma	0.000231	0.000347	CcSEcCtD
Telmisartan—Somnolence—Timolol—glaucoma	0.000231	0.000346	CcSEcCtD
Telmisartan—Rash—Clonidine—glaucoma	0.00023	0.000345	CcSEcCtD
Telmisartan—Dermatitis—Clonidine—glaucoma	0.00023	0.000345	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000229	0.00222	CbGpPWpGaD
Telmisartan—Headache—Clonidine—glaucoma	0.000229	0.000343	CcSEcCtD
Telmisartan—Dyspepsia—Timolol—glaucoma	0.000228	0.000343	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000228	0.00221	CbGpPWpGaD
Telmisartan—Asthenia—Betaxolol—glaucoma	0.000228	0.000342	CcSEcCtD
Telmisartan—Decreased appetite—Timolol—glaucoma	0.000226	0.000338	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.000225	0.00218	CbGpPWpGaD
Telmisartan—Pruritus—Betaxolol—glaucoma	0.000225	0.000337	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Timolol—glaucoma	0.000224	0.000336	CcSEcCtD
Telmisartan—Fatigue—Timolol—glaucoma	0.000224	0.000335	CcSEcCtD
Telmisartan—Pain—Timolol—glaucoma	0.000222	0.000333	CcSEcCtD
Telmisartan—Diarrhoea—Betaxolol—glaucoma	0.000217	0.000326	CcSEcCtD
Telmisartan—Nausea—Clonidine—glaucoma	0.000217	0.000325	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000216	0.0021	CbGpPWpGaD
Telmisartan—Feeling abnormal—Timolol—glaucoma	0.000214	0.000321	CcSEcCtD
Telmisartan—Gastrointestinal pain—Timolol—glaucoma	0.000212	0.000318	CcSEcCtD
Telmisartan—Dizziness—Betaxolol—glaucoma	0.00021	0.000315	CcSEcCtD
Telmisartan—Urticaria—Timolol—glaucoma	0.000206	0.000309	CcSEcCtD
Telmisartan—Body temperature increased—Timolol—glaucoma	0.000205	0.000308	CcSEcCtD
Telmisartan—Abdominal pain—Timolol—glaucoma	0.000205	0.000308	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—FAS—glaucoma	0.000204	0.00198	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000204	0.00197	CbGpPWpGaD
Telmisartan—Vomiting—Betaxolol—glaucoma	0.000202	0.000303	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—C3—glaucoma	0.000202	0.00195	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—OPN4—glaucoma	0.000202	0.00195	CbGpPWpGaD
Telmisartan—Rash—Betaxolol—glaucoma	0.0002	0.0003	CcSEcCtD
Telmisartan—Dermatitis—Betaxolol—glaucoma	0.0002	0.0003	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—PAX6—glaucoma	0.000199	0.00193	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—EDN1—glaucoma	0.000199	0.00193	CbGpPWpGaD
Telmisartan—Headache—Betaxolol—glaucoma	0.000199	0.000298	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.000197	0.00191	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CA1—glaucoma	0.000196	0.00189	CbGpPWpGaD
Telmisartan—Hypersensitivity—Timolol—glaucoma	0.000191	0.000287	CcSEcCtD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.00019	0.00184	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CTSA—glaucoma	0.000189	0.00183	CbGpPWpGaD
Telmisartan—Nausea—Betaxolol—glaucoma	0.000189	0.000283	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—HEYL—glaucoma	0.000187	0.00181	CbGpPWpGaD
Telmisartan—Asthenia—Timolol—glaucoma	0.000186	0.000279	CcSEcCtD
Telmisartan—Pruritus—Timolol—glaucoma	0.000184	0.000275	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—PTGFR—glaucoma	0.000182	0.00176	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CA2—glaucoma	0.000179	0.00173	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000178	0.00173	CbGpPWpGaD
Telmisartan—Diarrhoea—Timolol—glaucoma	0.000178	0.000266	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000175	0.00169	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000175	0.00169	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—C3—glaucoma	0.000174	0.00168	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000173	0.00167	CbGpPWpGaD
Telmisartan—Dizziness—Timolol—glaucoma	0.000172	0.000257	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000172	0.00166	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CA1—glaucoma	0.000167	0.00162	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000165	0.0016	CbGpPWpGaD
Telmisartan—Vomiting—Timolol—glaucoma	0.000165	0.000247	CcSEcCtD
Telmisartan—Rash—Timolol—glaucoma	0.000164	0.000245	CcSEcCtD
Telmisartan—Dermatitis—Timolol—glaucoma	0.000163	0.000245	CcSEcCtD
Telmisartan—Headache—Timolol—glaucoma	0.000163	0.000244	CcSEcCtD
Telmisartan—PPARG—Metabolism—CTSA—glaucoma	0.000162	0.00156	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP1B1—glaucoma	0.000157	0.00152	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—SMO—glaucoma	0.000155	0.0015	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	0.000155	0.0015	CbGpPWpGaD
Telmisartan—Nausea—Timolol—glaucoma	0.000154	0.000231	CcSEcCtD
Telmisartan—PPARG—Metabolism—CA2—glaucoma	0.000153	0.00148	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—CDKN2B—glaucoma	0.00015	0.00145	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000149	0.00144	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000149	0.00144	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000149	0.00144	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—glaucoma	0.000148	0.00143	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000147	0.00142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RPTOR—glaucoma	0.000142	0.00138	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NARFL—glaucoma	0.000138	0.00134	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA5A—glaucoma	0.000138	0.00134	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NCK2—glaucoma	0.000138	0.00133	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NARFL—glaucoma	0.000135	0.0013	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA5A—glaucoma	0.000135	0.0013	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NR3C1—glaucoma	0.000131	0.00127	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000129	0.00125	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TXN—glaucoma	0.000126	0.00122	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GSTM1—glaucoma	0.000125	0.00121	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	0.000124	0.0012	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA1—glaucoma	0.000122	0.00118	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000119	0.00115	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000118	0.00114	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CTSA—glaucoma	0.000118	0.00114	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000117	0.00113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HDAC9—glaucoma	0.000117	0.00113	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000115	0.00111	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000114	0.0011	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—EDN1—glaucoma	0.000112	0.00109	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA2—glaucoma	0.000111	0.00108	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00011	0.00107	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TXN—glaucoma	0.000108	0.00104	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EDN1—glaucoma	0.000102	0.000989	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—glaucoma	0.000101	0.000981	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000101	0.000977	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—C3—glaucoma	9.83e-05	0.000952	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.81e-05	0.00095	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTT1—glaucoma	9.77e-05	0.000946	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.72e-05	0.000941	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—glaucoma	9.2e-05	0.000891	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMO—glaucoma	9.15e-05	0.000886	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—C3—glaucoma	8.92e-05	0.000864	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—glaucoma	8.79e-05	0.000851	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—glaucoma	8.68e-05	0.000841	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.63e-05	0.000836	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK2—glaucoma	8.37e-05	0.000811	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTT1—glaucoma	8.34e-05	0.000807	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.07e-05	0.000781	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.88e-05	0.000763	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TXN—glaucoma	7.84e-05	0.000759	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1B1—glaucoma	7.79e-05	0.000754	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCA1—glaucoma	7.79e-05	0.000754	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CDKN2B—glaucoma	7.2e-05	0.000697	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NGFR—glaucoma	7.18e-05	0.000695	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK1—glaucoma	6.82e-05	0.000661	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA1—glaucoma	6.74e-05	0.000653	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.72e-05	0.000651	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCA1—glaucoma	6.64e-05	0.000643	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1B1—glaucoma	6.64e-05	0.000643	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—glaucoma	6.6e-05	0.000639	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA1—glaucoma	6.58e-05	0.000637	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CTSA—glaucoma	6.53e-05	0.000632	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CTSA—glaucoma	6.37e-05	0.000617	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.35e-05	0.000615	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR3C1—glaucoma	6.32e-05	0.000612	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN2B—glaucoma	6.29e-05	0.000609	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTM1—glaucoma	6.22e-05	0.000603	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA2—glaucoma	6.16e-05	0.000597	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTT1—glaucoma	6.08e-05	0.000589	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EDN1—glaucoma	6.03e-05	0.000584	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.02e-05	0.000583	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.02e-05	0.000583	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA2—glaucoma	6.02e-05	0.000583	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.01e-05	0.000582	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—glaucoma	5.93e-05	0.000574	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NGF—glaucoma	5.55e-05	0.000537	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTHFR—glaucoma	5.5e-05	0.000533	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—glaucoma	5.31e-05	0.000514	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—C3—glaucoma	5.27e-05	0.00051	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—glaucoma	5.12e-05	0.000496	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—glaucoma	5.08e-05	0.000492	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CAV1—glaucoma	5.07e-05	0.000491	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5e-05	0.000484	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—glaucoma	4.91e-05	0.000475	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CAV1—glaucoma	4.86e-05	0.000471	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1B1—glaucoma	4.84e-05	0.000469	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCA1—glaucoma	4.84e-05	0.000469	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—glaucoma	4.69e-05	0.000455	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FN1—glaucoma	4.63e-05	0.000448	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BAD—glaucoma	4.57e-05	0.000443	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—glaucoma	4.37e-05	0.000423	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TXN—glaucoma	4.34e-05	0.000421	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAV1—glaucoma	4.33e-05	0.000419	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.28e-05	0.000415	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TXN—glaucoma	4.24e-05	0.00041	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.96e-05	0.000384	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.93e-05	0.00038	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—glaucoma	3.87e-05	0.000375	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—glaucoma	3.84e-05	0.000372	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.78e-05	0.000366	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—glaucoma	3.68e-05	0.000356	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—glaucoma	3.51e-05	0.00034	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—glaucoma	3.42e-05	0.000331	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—glaucoma	3.37e-05	0.000326	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—glaucoma	3.29e-05	0.000318	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—glaucoma	3.27e-05	0.000317	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—glaucoma	3.19e-05	0.000309	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—glaucoma	3.18e-05	0.000308	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAV1—glaucoma	3.16e-05	0.000306	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—glaucoma	2.99e-05	0.00029	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—glaucoma	2.95e-05	0.000286	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.72e-05	0.000263	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1B1—glaucoma	2.68e-05	0.00026	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCA1—glaucoma	2.68e-05	0.00026	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—glaucoma	2.65e-05	0.000256	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1B1—glaucoma	2.62e-05	0.000254	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCA1—glaucoma	2.62e-05	0.000254	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—glaucoma	2.39e-05	0.000231	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—glaucoma	2.18e-05	0.000211	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—glaucoma	2.14e-05	0.000208	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—glaucoma	2.09e-05	0.000203	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—glaucoma	2e-05	0.000194	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—glaucoma	1.9e-05	0.000184	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—glaucoma	1.85e-05	0.000179	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—glaucoma	1.76e-05	0.000171	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAV1—glaucoma	1.75e-05	0.000169	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—glaucoma	1.72e-05	0.000167	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAV1—glaucoma	1.71e-05	0.000165	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—glaucoma	1.32e-05	0.000128	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—glaucoma	1.29e-05	0.000125	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—glaucoma	1.21e-05	0.000117	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—glaucoma	1.18e-05	0.000114	CbGpPWpGaD
